Neuphoria Therapeutics Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2023 to 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Neuphoria Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2023 to 2024.
  • Neuphoria Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$1.94M, a 57.3% increase year-over-year.
  • Neuphoria Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$15.5M, a 27.5% increase from 2023.
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$15.5M +$5.88M +27.5% Jul 1, 2023 Jun 30, 2024 10-Q 2025-02-14
2023 -$21.4M Jul 1, 2022 Jun 30, 2023 10-K 2024-09-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.